Baseer Ahmad, MD
Clinical Instructor, Ophthalmology, CWRU School of Medicine
Dr. Baseer Ahmad joined University Hospitals Eye Institute in 2014 as a medical and surgical vitreoretinal specialist.
Dr. Ahmad was born in Cleveland, but grew up in Erie, Pennsylvania. During high school, his family moved to Pakistan and he spent two years there as a teenager. He returned to the United States to attend college at the University of Texas at Dallas at the age of 16 and with a full scholarship. He studied electrical engineering there and interned at Siemens during his final year. After graduation he was hired as an engineer there, during which time he designed telecommunications hardware and wrote numerous software applications to automate human tasks.
While working at Siemens over the next three years, he finished pre-medical studies and was accepted to the University of Texas, Southwestern Medical Center at Dallas. Rather than leaving his engineering position at that point, he continued to work 30 hours weekly for another couple years while attending medical school. Ultimately, he resigned from his engineering work when clinical rotations began in the third year of medical school and it became unmanageable to do both things.
After finishing medical school, Dr. Ahmad completed an internship at Sinai-Grace hospital in Detroit, Michigan. He then moved back to his hometown of Cleveland to complete ophthalmology residency at the Cole Eye Institute of the Cleveland Clinic. Surgical fellowship training next took him to St. Louis where he trained at the Retina Institute of St. Louis (formerly Barnes Retina Institute). After completion of training, Dr. Ahmad’s desire to return to his hometown and to be involved in an academic/teaching environment brought him to Case Western Reserve University.
Dr. Ahmad attends to both adult and pediatric retinal disorders. He has an interest in surgical treatment of retinal detachments, proliferative retinopathies such as those in sickle cell disease and diabetes, macular holes, epiretinal membranes, and repair of complications from anterior segment surgery.
From a medical standpoint, Dr. Ahmad sees and manages retinal vascular disorders, macular degeneration, hereditary retinal dystrophies, and posterior uveitis.
Retinal Vascular Disease, Diabetic Retinopathy, Macular Degeneration Care, Retinal Dystrophies
American Board of Ophthalmology - Ophthalmology
Education & Training
2002, University of Texas at Dallas
Medical / Professional School(s):
2008, University of Texas Southwestern Medical Center
2009, Transitional Year - DMC Sinai Grace Hospital
2012, Ophthalmology - Cleveland Clinic
2014, Vitreo-Retinal Surgery and Disease - The Retina Institute
In addition to his main interest of caring for patients, Dr. Ahmad also participates in a number of clinical research endeavors, including the nationwide DRCR (Diabetic Retinopathy Clinical Research) network. He also participates in translational research involving animal models of diabetic retinopathy and macular degeneration. Additionally, Dr. Ahmad is actively involved with the retina image reading center at University Hospitals and serves as the primary adjudicator for fluorescein and tomographic studies conducted in several national clinical trials.
Patient Satisfaction Reviews
About Our Survey
At University Hospitals, we believe in providing patients with all the information they need to make educated decisions about their health care and to choose the right doctor to meet their needs. That is why we partner with the independent patient satisfaction company Press Ganey to survey patients about their experiences at UH facilities and with UH physicians. We hold ourselves to the highest standards of care and are dedicated to creating a positive patient experience for every individual who sees a UH doctor.
There are no comments for this practitioner.
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Baseer Ahmad, MD did not disclose any Outside Relationships with Industry.